Cargando…

Prevalence and characteristics of neuropsychiatric symptoms, quality of life and psychotropics in people with acquired brain injury in long‐term care

AIM: Establishing the prevalence of neuropsychiatric symptoms (NPS), quality of life and psychotropic drug use in people aged ≤65 years with acquired brain injury in nursing homes. DESIGN: Cross‐sectional, observational study among patients aged 18–≤65 years with acquired brain injury admitted to sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kohnen, Roy, Lavrijsen, Jan, Smals, Odile, Gerritsen, Debby, Koopmans, Raymond
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900174/ https://www.ncbi.nlm.nih.gov/pubmed/31318085 http://dx.doi.org/10.1111/jan.14156

Ejemplares similares

The prevalence and determinants of inappropriate sexual behaviour in people with acquired brain injury in nursing homes
por: Kohnen, Roy F., et al.
Publicado: (2021)

Time trends in psychotropic drug prescriptions in Dutch nursing home residents with dementia between 2003 and 2018
por: Du, Jiamin, et al.
Publicado: (2022)

Improving psychotropic drug prescription in nursing home patients with dementia: design of a cluster randomized controlled trial
por: Smeets, Claudia HW, et al.
Publicado: (2013)

PROPER I: frequency and appropriateness of psychotropic drugs use in nursing home patients and its associations: a study protocol
por: van der Spek, Klaas, et al.
Publicado: (2013)

Prolonged neuropsychiatric effects following management of chloroquine intoxication with psychotropic polypharmacy
por: Maxwell, Nicole M, et al.
Publicado: (2015)

Neuropsychiatric symptoms in patients with dementia in primary care: a study protocol
por: Borsje, Petra, et al.
Publicado: (2014)

Multi-psychotropic drug prescription and the association to neuropsychiatric symptoms in three Norwegian nursing home cohorts between 2004 and 2011
por: Gulla, Christine, et al.
Publicado: (2016)

Cannabinoid as Beneficial Replacement Therapy for Psychotropics to Treat Neuropsychiatric Symptoms in Severe Alzheimer’s Dementia: A Clinical Case Report
por: Defrancesco, Michaela, et al.
Publicado: (2020)

Process evaluation of a tailored intervention to Reduce Inappropriate psychotropic Drug use in nursing home residents with dementia
por: Groot Kormelinck, Claudia M., et al.
Publicado: (2021)

Prevalence and correlates of psychotropic drug use in Dutch nursing home patients with young‐onset dementia
por: Mulders, Ans J.M.J., et al.
Publicado: (2019)

Identifying and managing apathy in people with dementia living in nursing homes: a qualitative study
por: Nijsten, Johanna M. H., et al.
Publicado: (2023)

The construction of a conceptual framework explaining the relation between barriers to change of management of neuropsychiatric symptoms in nursing homes: a qualitative study using focus groups
por: van Teunenbroek, Charlotte F., et al.
Publicado: (2020)

Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors
por: García‐Domínguez, Laura, et al.
Publicado: (2022)

Using Video Feedback at Home in Dementia Care: A Feasibility Study
por: Gerritsen, Debby L., et al.
Publicado: (2018)

Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK
por: Alfageh, Basmah H., et al.
Publicado: (2019)

Bartonella Associated Cutaneous Lesions (BACL) in People with Neuropsychiatric Symptoms
por: Breitschwerdt, Edward B., et al.
Publicado: (2020)

Psychotropic drugs and driving: prevalence and types
por: Alonso, Francisco, et al.
Publicado: (2014)

“The educating nursing staff effectively (TENSE) study”: design of a cluster randomized controlled trial
por: Hazelhof, Theo J G M, et al.
Publicado: (2014)

Safety of psychotropic medications in people with COVID-19
por: Ostuzzi, G., et al.
Publicado: (2021)

Biweekly fluctuations of neuropsychiatric symptoms according to the Neuropsychiatric Inventory: Erratic symptoms or scores?
por: Eikelboom, Willem S., et al.
Publicado: (2022)

The course of neuropsychiatric symptoms and psychotropic drug use in Dutch nursing home patients with dementia during the first wave of COVID‐19: A longitudinal cohort study
por: Sizoo, Eefje M., et al.
Publicado: (2022)

The Impact of Visitation Guidelines During COVID-19 on Well-Being and Daily Life in Nursing Homes
por: Gerritsen, Debby, et al.
Publicado: (2021)

From wave to wave: a Dutch national study on the long-term impact of COVID-19 on well-being and family visitation in nursing homes
por: Backhaus, Ramona, et al.
Publicado: (2021)

Reducing inappropriate psychotropic drug use in nursing home residents with dementia: protocol for participatory action research in a stepped-wedge cluster randomized trial
por: Groot Kormelinck, Claudia M., et al.
Publicado: (2019)

The effects of the COVID-19 virus on mental healthcare for older people in The Netherlands
por: Gerritsen, Debby L., et al.
Publicado: (2020)

Examining Association of Personality Characteristics and Neuropsychiatric Symptoms in Post-COVID Syndrome
por: Delgado-Alonso, Cristina, et al.
Publicado: (2022)

Treating psychiatric symptoms and disorders with non-psychotropic medications 
por: Hede, Vincent, et al.
Publicado: (2019)

The psychotropic effect of vitamin D supplementation on schizophrenia symptoms
por: Neriman, Aras, et al.
Publicado: (2021)

Neuropsychiatric symptoms and celiac disease
por: Urban-Kowalczyk, Małgorzata, et al.
Publicado: (2014)

Neuropsychiatric symptoms and severity of dementia
por: Caldas, Gustavo Henrique de Oliveira, et al.
Publicado: (2013)

Implementing a Personalized Integrated Stepped-Care Method (STIP-Method) to Prevent and Treat Neuropsychiatric Symptoms in Persons With Dementia in Nursing Homes: Protocol for a Mixed Methods Study
por: Verstraeten, Helma M F, et al.
Publicado: (2022)

Symptom dimensions of anxiety in Parkinson’s disease: Replication study in a neuropsychiatric patient population
por: Rutten, Sonja, et al.
Publicado: (2021)

Psychotropic medication for challenging behavior in people with learning disabilities in Qatar
por: Eltorki, Y., et al.
Publicado: (2021)

Nutritional supplements for neuropsychiatric symptoms in people with dementia: A systematic review and meta‐analysis
por: Haider, Sandra, et al.
Publicado: (2020)

Blood pressure, antihypertensive medication and neuropsychiatric symptoms in older people with dementia: The COSMOS study
por: de Jong‐Schmit, Bianca E. M., et al.
Publicado: (2020)

Associations between Neuropsychiatric Symptoms and Alzheimer’s Disease Biomarkers in People with Mild Cognitive Impairment
por: Arenare, Giulia, et al.
Publicado: (2023)

Neuropsychiatric profile and psychotropic medication use in adults with autism spectrum disorder: results from the Australian Longitudinal Study of Adults with Autism
por: Cvejic, Rachael C., et al.
Publicado: (2018)

Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19
por: Kappelmann, Nils, et al.
Publicado: (2021)

Is patient-grouping on basis of condition on admission indicative for discharge destination in geriatric stroke patients after rehabilitation in skilled nursing facilities? The results of a cluster analysis
por: Buijck, Bianca I, et al.
Publicado: (2012)

Losing hope or keep searching for a golden solution: an in-depth exploration of experiences with extreme challenging behavior in nursing home residents with dementia
por: Veldwijk-Rouwenhorst, Annelies E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ap2edll718upancjkv30h74v94